CVS Health Corporation
CVS
$77.27
-$1.83-2.31%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.76% | 8.35% | 6.92% | 3.65% | 6.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.76% | 8.35% | 6.92% | 3.65% | 6.02% |
| Cost of Revenue | 7.48% | 9.60% | 5.69% | 6.10% | 8.77% |
| Gross Profit | 9.71% | 0.90% | 14.61% | -10.76% | -9.71% |
| SG&A Expenses | 3.42% | 1.08% | 4.48% | 0.76% | 7.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.02% | 8.61% | 5.55% | 5.49% | 8.61% |
| Operating Income | 53.48% | 0.22% | 66.51% | -44.82% | -57.11% |
| Income Before Tax | -3,416.19% | -29.53% | 65.63% | -21.40% | -96.52% |
| Income Tax Expenses | 1,394.12% | 11.42% | 83.11% | -23.56% | -95.49% |
| Earnings from Continuing Operations | -5,719.72% | -42.70% | 58.54% | -20.71% | -96.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -6.25% | 300.00% | 72.73% | 2,200.00% | 500.00% |
| Net Income | -4,668.97% | -42.32% | 59.84% | -19.65% | -96.15% |
| EBIT | 53.48% | 0.22% | 66.51% | -44.82% | -57.11% |
| EBITDA | 29.21% | 0.67% | 42.73% | -33.42% | -42.52% |
| EPS Basic | -4,633.14% | -42.77% | 59.72% | -17.80% | -96.07% |
| Normalized Basic EPS | 61.80% | 2.56% | 76.94% | -35.73% | -55.49% |
| EPS Diluted | -4,633.14% | -43.23% | 60.23% | -17.80% | -96.05% |
| Normalized Diluted EPS | 61.80% | 2.48% | 77.52% | -35.58% | -55.39% |
| Average Basic Shares Outstanding | 0.79% | 0.80% | 0.08% | -2.25% | -2.18% |
| Average Diluted Shares Outstanding | 0.79% | 0.87% | -0.24% | -2.47% | -2.40% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 9.92% | 9.92% |
| Payout Ratio | -1.02% | 0.75% | -0.37% | 0.34% | 26.92% |